01.07.2024,
3328 Zeichen
Copenhagen, Denmark (ots/PRNewswire) - Dawn Health, the digital
health company pioneering patient-first innovation, has announced
they are working with leading global pharmaceutical company, Merck,
on a digital solution for Growth Hormone Disorders (GHD).
Over the next two years, they will join forces to deliver a
cutting-edge, user-centric digital platform, designed to help improve
the lives of tens of thousands of patients across more than 40
countries.
By harnessing the latest AI technologies, the collaboration will also
involve exploring the integration of features such as growth
predictions and advanced personalization into the digital product,
with excitement about AI and its potential for impact on user
experience, adoption, adherence, and treatment outcomes. The digital
solution will provide support to children and young adults living
with GHD, as well as providing tools and support to their caregivers,
both at home and in a clinical setting.
With a shared commitment to improving patient lives, the
collaboration will focus on patient-centricity to deliver an
intuitive, engaging product that supports users and caregivers
throughout their treatment journey. This means speaking with patients
to truly understand their unmet needs and how the solution can best
address these, as well as hearing from caregivers and healthcare
professionals about how to best empower and support those living with
GHD.
The collaboration is already off to a strong start, with workshops
and inspiring discussions happening between the teams at Dawn Health
and Merck, as they work together to deliver a cutting-edge platform
on a global scale to improve the lives of people living with Growth
Hormone Disorders.
About Merck
Merck, a leading science and technology company, operates across life
science, healthcare and electronics. Around 63,000 employees work to
make a positive difference to millions of people's lives every day by
creating more joyful and sustainable ways to live. From providing
products and services that accelerate drug development and
manufacturing as well as discovering unique ways to treat the most
challenging diseases to enabling the intelligence of devices – the
company is everywhere. In 2023, Merck generated sales of € 21 billion
in 65 countries. Scientific exploration and responsible
entrepreneurship have been key to Merck's technological and
scientific advances. This is how Merck has thrived since its founding
in 1668. The founding family remains the majority owner of the
publicly listed company. Merck holds the global rights to the Merck
name and brand. The only exceptions are the United States and Canada,
where the business sectors of Merck operate as MilliporeSigma in life
science, EMD Serono in healthcare, and EMD Electronics in
electronics.
All Merck press releases are distributed by e-mail at the same time
they become available on the Merck website. Please go to
www.merckgroup.com/subscribe to register online, change your
selection or discontinue this service.
About Dawn Health
Dawn Health is a global leader in digital health, specializing in the
development of software as a medical device (SaMD) and digital
therapeutics (DTx). Partnering with pharmaceutical companies, Dawn
Health accelerates the launch of digital solutions to change the
lives of people with chronic conditions.
constance.de-quinsonas@merckgroup.com
BSN Podcasts
Christian Drastil: Wiener Börse Plausch
Wiener Börse Party #697: Kleiner Verfallstag beim ATX, grosser Verfallstag bei Crowdstrike, Do&Co mutig und wir geprinted
Aktien auf dem Radar:Zumtobel, FACC, Bawag, Austriacard Holdings AG, Lenzing, AT&S, Telekom Austria, EVN, Strabag, CA Immo, Immofinanz, Agrana, Hutter & Schrantz Stahlbau, Marinomed Biotech, Warimpex, RHI Magnesita, Oberbank AG Stamm, Athos Immobilien, Amag, Erste Group, Flughafen Wien, Österreichische Post, S Immo, Uniqa, VIG, Wienerberger, Commerzbank, Deutsche Telekom, BASF, Fresenius, Sartorius.
RWT AG
Die Firma RWT Hornegger & Thor GmbH wurde 1999 von den beiden Geschäftsführern Hannes Hornegger und Reinhard Thor gegründet. Seitdem ist das Unternehmen kontinuierlich, auf einen derzeitigen Stand von ca. 30 Mitarbeitern, gewachsen. Das Unternehmen ist in den Bereichen Werkzeugbau, Formenbau, Prototypenbau und Baugruppenfertigung tätig und stellt des Weiteren moderne Motorkomponenten und Präzisionsteile her.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Mehr aktuelle OTS-Meldungen HIER